Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

1.25
Delayed Data
As of May 17
 +0.19 / +17.92%
Today’s Change
0.88
Today|||52-Week Range
7.72
-46.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues22.0K1.0M1.4M1.0M
 
 
 
 
 
Depreciation And Amortization73.0K74.0K82.0K83.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses4.5M7.6M6.9M8.7M
 
 
 
 
 
Research And Development3.9M6.9M5.6M7.1M
 
 
 
 
 
Total Operating Expenses4.6M7.6M7.0M8.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-6.6M-5.6M-7.7M
 
 
 
 
 
Extraordinary Credit3.1M0.000.000.00
 
 
Extraordinary Charge0.00-1.4M0.000.00
 
 
Pre-Tax Equity Earnings0.00-20.0K-19.0K-442.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.4M-7.9M-5.4M-8.1M
 
 
 
 
 
Preferred Dividend-535.0K-5.0K0.000.00
 
 
 
Net Income-1.4M-7.9M-5.4M-8.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.2M4.0M8.1M8.1M
 
 
 
 
 
Shares To Calculate EPS Diluted8.2M4.0M8.1M8.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$1.97-$0.67-$0.99
 
 
 
 
 
EPS Diluted-$0.24-$1.97-$0.67-$0.99